Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study.

Kathleen N.  Moore

Consulting or Advisory Role - Advaxis; Aravive; AstraZeneca; Clovis Oncology; Genentech/Roche; Immunogen; Janssen Oncology; Merck; OncoMed; Pfizer/EMD Serono; Samumed; TESARO; VBL Therapeutics

Speakers' Bureau - AstraZeneca

Research Funding - Abbvie/Stemcentrx (Inst); Advaxis (Inst); Agenus (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Forty Seven (Inst); Genentech (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Stem CentRx (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)

Travel, Accommodations, Expenses - Genentech/Roche

Other Relationship - AstraZeneca

Setsuko K.  Chambers

Consulting or Advisory Role - HERON

Erika Paige  Hamilton

Consulting or Advisory Role - Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Flatiron Health; Genentech/Roche (Inst); Lilly (Inst); Mersana (Inst); Pfizer (Inst); Puma Biotechnology (Inst)

Research Funding - Abbvie (Inst); Acerta Pharma (Inst); ArQule (Inst); AstraZeneca (Inst); BerGenBio (Inst); Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); Clovis Oncology (Inst); Curis (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); eFFECTOR Therapeutics (Inst); Eisai (Inst); EMD Serono (Inst); Fujifilm (Inst); Genentech/Roche (Inst); H3 Biomedicine (Inst); Hutchison MediPharma (Inst); Immunomedics (Inst); InventisBio (Inst); Kadmon (Inst); Leap Therapeutics (Inst); Lilly (Inst); Lycera (Inst); Macrogenics (Inst); Mallinckrodt (Inst); MedImmune (Inst); Medivation (Inst); Mersana (Inst); Merus (Inst); Millennium (Inst); Novartis (Inst); Nucana (Inst); OncoMed (Inst); Oncothyreon (Inst); Pfizer (Inst); PharmaMar (Inst); Radius Health (Inst); Regeneron (Inst); Rgenix (Inst); Stem CentRx (Inst); Syndax (Inst); Syros Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TapImmune Inc. (Inst); Tesaro (Inst); TetraLogic Pharmaceuticals (Inst); Verastem (Inst); Zymeworks (Inst)

Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; EMD Serono; Foundation Medicine; Genentech; Genentech/Roche; Genzyme; Guardant Health; Helsinn Therapeutics; HERON; Lexicon; Lilly; Lilly; Medivation; Merck; Novartis; Pfizer; Roche; Sysmex; Tesaro

Lee-may  Chen

Research Funding - Abbvie; AstraZeneca; Clovis Oncology; Roche; Tesaro

Amit M.  Oza

Honoraria - Intas

Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)

Travel, Accommodations, Expenses - AstraZeneca

Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro

Sharad A.  Ghamande

Honoraria - Advaxis

Consulting or Advisory Role - Advaxis

Speakers' Bureau - Tesaro

Research Funding - AstraZeneca; GlaxoSmithKline; Merck; Roche; Takeda; Tesaro

Gottfried E.  Konecny

Speakers' Bureau - AstraZeneca; Clovis Oncology; Tesaro

Research Funding - Merck

Travel, Accommodations, Expenses - Novartis

Steven C.  Plaxe

Stock and Other Ownership Interests  - Abbott Laboratories; Abbvie

Research Funding - AstraZeneca (Inst); BIND Therapeutics (Inst); Endocyte (Inst); incyte (Inst); Janssen Oncology (Inst); kevelt (Inst); MedImmune (Inst); Millennium (Inst); Novartis (Inst); pfizer (Inst); PharmaMar (Inst); Tesaro (Inst)

Daniel Lewis  Spitz

No Relationships to Disclose

Jill J.J.  Geenen

No Relationships to Disclose

Tiffany A.  Troso-Sandoval

Honoraria - Bio Ascend

Travel, Accommodations, Expenses - Bio Ascend

Janiel M.  Cragun

No Relationships to Disclose

Esteban  Rodrigo Imedio

Employment - AstraZeneca; Boehringer Ingelheim

Sanjeev  Kumar

Employment - AstraZeneca

Stock and Other Ownership Interests  - AstraZeneca

Travel, Accommodations, Expenses - AstraZeneca

Ganesh M.  Mugundu

No Relationships to Disclose

Zhongwu  Lai

Employment - AstraZeneca

Stock and Other Ownership Interests  - AstraZeneca; crispr therapeutics; Spectrum Pharmaceuticals

Juliann  Chmielecki

No Relationships to Disclose

Suzanne Fields  Jones

Consulting or Advisory Role - Clovis Oncology (Inst); Janssen (Inst); Novartis (Inst); Onyx (Inst); Teva (Inst); Vertex (Inst)

David R.  Spigel

Leadership - TriStar Centennial Medical Center

Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Evelo Therapeutics (Inst); Foundation Medicine (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Illumina (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Precision Oncology (Inst); Takeda (Inst); TRM Oncology (Inst)

Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Aeglea Biotherapeutics (Inst); Amgen (Inst); ARMO BioSciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Foundation Medicine (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Nektar (Inst); Neon Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Pfizer (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst)

Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Genzyme; Intuitive Surgical; Lilly; Merck; Pfizer; Purdue Pharma; Spectrum Pharmaceuticals; Sysmex

Karen Anne  Cadoo

Research Funding - AstraZeneca (Inst); Syndax (Inst)

Travel, Accommodations, Expenses - AstraZeneca